• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT Back to Search Results
Model Number 778626
Device Problem Biocompatibility (2886)
Patient Problem Fever (1858)
Event Date 05/19/2023
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that the customer removed the ureteral stent (778626) from the packaging box during use.Before passing the stent through the guide wire, the customer pulled apart the wire and applied a gentle transverse pull force to the stent.The stent was ruptured and replaced with a new one (778626) to continue the procedure.After operation, the patient had a fever.Since the problem had occurred at the this hospital for the third time, the doctors¿ confidence in this product had been severely impacted.The hospital asked the company to explain about the stent ruptures and hopes the company to pay more attention to this.It was unknown what medical intervention was provided for the infection.
 
Manufacturer Narrative
The reported event is inconclusive as no sample was returned for evaluation.Visual evaluation noted one photo sample received.Photo sample shows outer product packaging indicating product catalog number, lot number, and expiration date.The sample received cannot be evaluated for the reported event due to sample condition.Although an exact root cause could not be determined a potential root cause could be material selection.A dhr review did not show any problems or conditions that would have contributed to the reported event.The instructions for use were found adequate and state the following: "precautions: the insertion of a ureteral stent should only be done by those individuals who have comprehensive training in the techniques and risks of the procedure.Potential complications: potential complications associated with retrograde/antegrade positioning of indwelling ureteral.Stents include the following: edema; stone formation; peritonitis; extravasation; ureteral reflux; stent dislodgement; fistula formation; loss of renal function fragmentation, migration, occlusion; hemorrhage; pain/discomfort; stent encrustation; hydronephrosis; perforation of kidney, renal; ureteral erosion; infection pelvis, ureter and/or bladder; urinary symptoms".H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text: the actual/suspected device was inspected.
 
Event Description
It was reported that the customer removed the ureteral stent (778626) from the packaging box during use.Before passing the stent through the guide wire, the customer pulled apart the wire and applied a gentle transverse pull force to the stent.The stent was ruptured and replaced with a new one (778626) to continue the procedure.After operation, the patient had a fever.Since the problem had occurred at the this hospital for the third time, the doctors¿ confidence in this product had been severely impacted.The hospital asked the company to explain about the stent ruptures and hopes the company to pay more attention to this.It was unknown what medical intervention was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY® URETERAL STENT
Type of Device
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington 30014
7707846100
MDR Report Key17117932
MDR Text Key317138959
Report Number1018233-2023-04284
Device Sequence Number1
Product Code FAD
UDI-Device Identifier00801741014833
UDI-Public(01)00801741014833
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K983498
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number778626
Device Catalogue Number778626
Device Lot NumberNGGV5132
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/19/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/19/2023
Initial Date FDA Received06/13/2023
Supplement Dates Manufacturer Received11/03/2023
Supplement Dates FDA Received11/07/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/30/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-